サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：キャリアスクリーニング市場- 世界の産業規模、シェア、動向、機会、および予測、2017年～2027年タイプ別、スクリーニングタイプ別、技術別、適応症別、エンドユーザー別、企業別、および地域別にセグメント化
市場調査レポート
商品コード
1289643

キャリアスクリーニング市場- 世界の産業規模、シェア、動向、機会、および予測、2017年～2027年タイプ別、スクリーニングタイプ別、技術別、適応症別、エンドユーザー別、企業別、および地域別にセグメント化

Carrier Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Screening Type, By Technology, By Indication, By End User, By Company, and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 118 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

キャリアスクリーニング市場- 世界の産業規模、シェア、動向、機会、および予測、2017年～2027年タイプ別、スクリーニングタイプ別、技術別、適応症別、エンドユーザー別、企業別、および地域別にセグメント化
出版日: 2023年06月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

キャリアスクリーニングの世界市場は、予測期間2023-2027年に目覚ましい成長を遂げると予測されています。

主な要因としては、遺伝性疾患の増加、早期発見と予防の重視の高まり、ゲノミクス分野の技術開拓などが挙げられ、市場の成長に拍車をかけています。遺伝的疾患とは、正常なDNA配列の変異に起因する疾患のことです。キャリアスクリーニングは、遺伝子疾患を持つ子供を持つリスクを知るのに役立つ検査の一種です。健康な人が鎌状赤血球症、嚢胞性線維症などの遺伝性疾患の劣性遺伝子を含んでいるかどうかを判定するものです。その他の市場開拓要因としては、政府による研究開発活動への投資の増加、新しいキャリアスクリーニング検査のリリースや承認の増加、世界の出生率の上昇、個別化医療への注目の高まり、キャリアスクリーニングに対する国民の意識の高まり、母親の年齢の上昇、大量遺伝子検査プログラムの利用、染色体異常の高い発生率があげられます。

遺伝性疾患の有病率の上昇

遺伝子や染色体の変異による遺伝性疾患や胎児の染色体異常の発生率が上昇していることが、世界の市場の成長を後押ししています。例えば、米国では、遺伝性疾患が新生児死亡の主な原因となっており、年間乳児死亡数の20％近くを占めています。嚢胞性線維症、テイ・サックス病、鎌状赤血球貧血などの遺伝性疾患は、両親の遺伝性疾患により発症し、子孫に遺伝することがあります。世界保健機関（WHO）によると、2019年には、約2～5％の乳児が遺伝性疾患や染色体異常を持っているとされています。新生児における障害の発生が増加しているため、出生前検査の需要の急増が市場の成長を後押ししています。

複雑な遺伝性疾患の早期発見と予防の重要性の高まり

近年、遺伝性疾患に対する認識が高まり、赤ちゃんのケアを計画的に行うことができるようになりました。都市部の親たちの間で出産を遅らせようとする傾向が強まっていることや、母親の平均年齢が高いことが妊娠合併症につながることが、市場の成長を促進する一因となっています。早期発見により、夫婦は妊娠の初期段階で遺伝性疾患や障害を持つ子供を持つリスクを知ることができます。このように、複雑な遺伝性疾患の早期発見と予防に注目が集まっていることが、世界的に市場の成長を後押ししています。早期キャリアスクリーニングのために、政府や非政府組織によってさまざまな取り組みが行われています。例えば、2018年には、ドバイ保健当局によって「ステップワン新生児スクリーニング」が導入されました。

技術的進歩が市場成長を促進します。

ゲノム分野の先端技術導入の高まりが、市場の成長を増強しています。キャリアスクリーニング法の技術的進歩により、検査技術の信頼性と利便性が向上しています。例えば、2022年、アメリカの科学製品サプライヤーであるThermo Fisher Scientific Inc.は、遺伝子発現を含む遺伝子障害のスキャンを支援する単一ソリューションのキャリアスクリーニング手法の一種であるNGSベースのテストキットの発売を発表しました。

カスタマイズの可能性

TechSci Researchは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です：

企業情報

  • 追加の市場企業の詳細な分析とプロファイリング（最大5社）。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のキャリアスクリーニング市場に与える影響

第5章 VOC (顧客の声)

第6章 キャリアスクリーニングの世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（拡大キャリアスクリーニングvsターゲットがんスクリーニング）
    • スクリーニングタイプ別（出生前キャリアスクリーニング／受胎前キャリアスクリーニング）
    • 技術別（次世代シーケンサー、ポリメラーゼ連鎖反応、マイクロアレイ、その他）
    • 適応症別（嚢胞性線維症、ダウン症、サラセミア、テイサックス病、ハンチントン病、鎌形赤血球貧血、その他）
    • エンドユーザー別（病院・クリニック、レファレンスラボラトリー、その他）
    • 地域別
    • 企業別（2021年）
  • 市場マップ

第7章 北米のキャリアスクリーニング市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別
    • スクリーニングの種類別
    • 技術別
    • 適応症別
    • エンドユーザー別
    • 国別
  • 北米における国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州のキャリアスクリーニング市場の展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • タイプ別
    • スクリーニングの種類別
    • 技術別
    • 適応症別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域のキャリアスクリーニング市場の展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • タイプ別
    • スクリーニングの種類別
    • 技術別
    • 適応症別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域の国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のキャリアスクリーニングの市場の展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェア・予測
    • タイプ別
    • スクリーニングの種類別
    • 技術別
    • 適応症別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのキャリアスクリーニングの市場の展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • タイプ別
    • スクリーニングの種類別
    • 技術別
    • 適応症別
    • エンドユーザー別
    • 国別
  • MEAの国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と開拓

第14章 競合情勢（SWOT分析も含む）

  • Eurofins Scientific, Inc.
  • Fulgent Genetics, Inc.
  • CENTOGENE N.V.
  • Invitae Corporation
  • Illumina, Inc.
  • Gene by Gene, Ltd.
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Myriad Genetics, Inc.
  • Quest Diagnostics, Inc.

第15章 戦略的な提言

目次
Product Code: 13043

The global carrier screening market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include increasing occurrences of genetic conditions, rising emphasis on early detection and prevention, and technological developments in the field of genomics that are fueling the growth of the market. Genetic conditions are diseases caused due to mutations in the normal DNA sequence. Carrier screening is a kind of test that helps to know the risk of having a child with a genetic disorder. It determines whether a healthy person contains the recessive gene of genetic diseases such as sickle cell disease, cystic fibrosis, and others. The other factors supporting the market's growth are rising investments in research and developments activities by the government, rise in numerous releases and approvals of new carrier screening tests, increasing birth rate across the globe, rising focus on personalized medicine, growing awareness of carrier screening among the population, increasing maternal age, availability of mass genetic testing programs, and the high incidence of chromosomal disorders.

Rising Prevalence of Genetic Diseases

The rising incidences of genetic disorders and fetal chromosomal anomalies due to mutation in genes or chromosomes are bolstering the growth of the market globally. For instance, in the U.S., genetic diseases are the primary cause of newborn deaths, accounting for nearly 20% of annual infant mortality. Genetic diseases such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia occur due to inheritable genetic conditions present in parents, which may get inherited by the offspring. According to the World Health Organization (WHO), in 2019, about 2 to 5% of infants had genetic diseases or chromosomal abnormalities. Owing to the increasing occurrences of disabilities in newborns, the surge in demand for prenatal testing is propelling the growth of the market.

Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders

In recent years, people have become more aware of genetic disorders, which enables them to plan and take better care of their babies. The growing inclination among urban parents to delay childbearing and the higher average age of mothers lead to pregnancy complications, which is a contributing factor to facilitating the growth of the market. Early detection helps couples to know the risk of having a child with genetic diseases or disorders in an early stage of pregnancy. Thus, the rising focus on early detection and prevention of complex genetic disorders is fueling the growth of the market globally. Various initiatives are taken by government and non-government organizations for early carrier screening. For instance, in 2018, "Step One Newborn Screening" was introduced by the Dubai health authority.

Technological Advancements fuel the Market Growth.

The rise in the adoption of advanced technology in the field of genomics sector is augmenting the growth of the market. The testing techniques are becoming more reliable and convenient because of technological advancements in carrier screening methods. For instance, in 2022, Thermo Fisher Scientific Inc., an American supplier of scientific products, announced the launch of an NGS-based test kit, which is a type of carrier screening approach in single solution that assists in scanning genetic disorders, including gene expression.

Market Segmentation

The global carrier screening market is segmented into type, screening type, technology, indication, end user, and company. Based on type, the market is divided into expanded carrier screening and targeted cancer screening. Based on screening type, the market is divided into prenatal carrier testing and preconception carrier screening. Based on technology, the market is divided into next-generation sequencing, polymerase chain reaction, microarrays, and others. Based on indication, the market is divided into cystic fibrosis, down's syndrome, thalassemia, tay sachs disease, Huntington's disease, sickle cell anemia, and others. Based on end-user, the market is divided into hospitals & clinics, reference laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the increasing incidences of genetic conditions and technological advancements in the country.

Market Players

Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc are some of the leading companies operating in the market.

Report Scope

In this report, global carrier screening market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Carrier Screening Market, By Type:

  • Expanded Carrier Screening
  • Targeted Cancer Screening

Carrier Screening Market, By Screening Type:

  • Prenatal Carrier Testing
  • Preconception Carrier Screening

Carrier Screening Market, By Technology:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others

Carrier Screening Market, By Indication:

  • Cystic Fibrosis
  • Down's Syndrome
  • Thalassemia
  • Tay-Sachs Disease
  • Huntington's Disease
  • Sickle Cell Anemia
  • Others

Carrier Screening Market, By End User:

  • Hospitals & Clinics
  • Reference Laboratories
  • Others

Carrier Screening Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Carrier Screening Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Carrier Screening Market

5. Voice of Customer

6. Global Carrier Screening Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Expanded Carrier Screening v/s Targeted Cancer Screening)
    • 6.2.2. By Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening)
    • 6.2.3. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, Others)
    • 6.2.4. By Indication (Cystic Fibrosis, Down's Syndrome, Thalassemia, Tay-Sachs Disease, Huntington's Disease, Sickle Cell Anemia, Others)
    • 6.2.5. By End User (Hospitals & Clinics, Reference Laboratories, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2021)
  • 6.3. Market Map

7. North America Carrier Screening Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Screening Type
    • 7.2.3. By Technology
    • 7.2.4. By Indication
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Carrier Screening Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Screening Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Indication
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Carrier Screening Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Screening Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Indication
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Carrier Screening Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Screening Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Indication
        • 7.3.3.2.5. By End User

8. Europe Carrier Screening Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Screening Type
    • 8.2.3. By Technology
    • 8.2.4. By Indication
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Carrier Screening Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Screening Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Indication
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Carrier Screening Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Screening Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Indication
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Carrier Screening Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Screening Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Indication
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Carrier Screening Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Screening Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Indication
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Carrier Screening Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Screening Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Indication
        • 8.3.5.2.5. By End User

9. Asia-Pacific Carrier Screening Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Screening Type
    • 9.2.3. By Technology
    • 9.2.4. By Indication
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Carrier Screening Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Screening Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Indication
        • 9.3.1.2.5. By End User
    • 9.3.2. India Carrier Screening Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Screening Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Indication
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Carrier Screening Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Screening Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Indication
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Carrier Screening Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Screening Type
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Indication
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Carrier Screening Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Screening Type
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Indication
        • 9.3.5.2.5. By End User

10. South America Carrier Screening Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Screening Type
    • 10.2.3. By Technology
    • 10.2.4. By Indication
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Carrier Screening Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Screening Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Indication
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Carrier Screening Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Screening Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Indication
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Carrier Screening Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Screening Type
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Indication
        • 10.3.3.2.5. By End User

11. Middle East and Africa Carrier Screening Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Screening Type
    • 11.2.3. By Technology
    • 11.2.4. By Indication
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Carrier Screening Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Screening Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Indication
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Carrier Screening Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Screening Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Indication
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Carrier Screening Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Screening Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Indication
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive of SWOT Analysis)

  • 14.1. Eurofins Scientific, Inc.
  • 14.2. Fulgent Genetics, Inc.
  • 14.3. CENTOGENE N.V.
  • 14.4. Invitae Corporation
  • 14.5. Illumina, Inc.
  • 14.6. Gene by Gene, Ltd.
  • 14.7. Laboratory Corporation of America Holdings
  • 14.8. Natera, Inc.
  • 14.9. Myriad Genetics, Inc.
  • 14.10. Quest Diagnostics, Inc.

15. Strategic Recommendations